EP
BHVN icon

Elkhorn Partners’s Biohaven BHVN Stock Holding History

Elkhorn Partners’s Portfolio BHVN Stock Details BHVN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$16.4K Sell
1,100
-900
-45% -$9.69K 0.01% 48
2026
Q1 		$16.9K Buy
2,000
+500
+33% +$5.47K 0.01% 44
2025
Q4 		$16.9K Sell
1,500
-4,400
-75% -$54.5K 0.01% 43
2025
Q3 		$88.6K Buy
5,900
+100
+2% +$1.46K 0.06% 25
2025
Q2 		$81.8K Buy
5,800
+1,200
+26% +$21.4K 0.06% 29
2025
Q1 		$111K Buy
4,600
+1,300
+39% +$45.8K 0.07% 23
2024
Q4 		$123K Buy
3,300
+1,100
+50% +$51.3K 0.08% 24
2024
Q3 		$110K Sell
2,200
-1,400
-39% -$54.5K 0.07% 29
2024
Q2 		$125K Buy
+3,600
New +$142K 0.09% 27
2022
Q4 		– Sell
-102
Closed -$15K – 42
2022
Q3 		$15K Buy
+102
New +$740 0.01% 41

Other funds holding BHVN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
Stifel Financial
Stifel Financial St. Louis, Missouri $120B AUM 27.84% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
IAM
Infinitum Asset Management Fort Lauderdale, Florida $983M AUM 26.53% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Elkhorn Partners's BHVN Position: Q2 2026 in Review

Elkhorn Partners reduced its Biohaven (BHVN) stake by 45% in Q2 2026, selling an estimated $9.69K and leaving 1,100 shares worth $16.4K. The position accounts for 0.01% of the portfolio, ranked #48.

Elkhorn Partners first reported a position in BHVN in Q3 2022 and has held it in 10 quarters since. The position peaked at $125K in Q2 2024. 296 funds tracked by Wall St. Rank hold BHVN as of Q2 2026.

  • Elkhorn Partners held 1,100 shares of Biohaven worth $16.4K as of Q2 2026.
  • Elkhorn Partners sold 900 Biohaven shares in Q2 2026, an estimated $9.69K.
  • Biohaven made up 0.01% of Elkhorn Partners's portfolio in Q2 2026, its #48 holding.
  • Elkhorn Partners first reported a position in Biohaven in Q3 2022 and has held it in 10 quarters since.
  • Elkhorn Partners's Biohaven position peaked at $125K in Q2 2024.
  • 296 funds tracked by Wall St. Rank held Biohaven as of Q2 2026.

Based on Elkhorn Partners's 13F filing for Q2 2026, filed 13 Aug 2026.